Chemoinformaics analysis of 1-METHOXY-4-METHYL-2-PROPAN-2-YLBENZENE
| Molecular Weight | 164.248 | nRot | 2 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 20 |
| Exact Molecular Weight | 164.12 | nRing | 1 |
| Solubility: LogS | -5.427 | nHRing | 0 |
| Solubility: LogP | 5.023 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 29.8407 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.626 |
| Synth | 4.304 |
| Natural Product Likeliness | 2.146 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.036 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.689 |
| MDCK | 0.000022 |
| BBB | 0.232 |
| PPB | 0.982225 |
| VDSS | 1.433 |
| FU | 0.0281157 |
| CYP1A2-inh | 0.189 |
| CYP1A2-sub | 0.592 |
| CYP2c19-inh | 0.129 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.272 |
| CYP2c9-sub | 0.579 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.833 |
| CYP3a4-inh | 0.316 |
| CYP3a4-sub | 0.411 |
| CL | 20.325 |
| T12 | 0.067 |
| hERG | 0.053 |
| Ames | 0.021 |
| ROA | 0.017 |
| SkinSen | 0.924 |
| Carcinogencity | 0.054 |
| EI | 0.036 |
| Respiratory | 0.704 |
| NR-Aromatase | 0.107 |
| Antiviral | No |
| Prediction | 0.786482 |